Dr. H. Tarik Kani talks to Dr. Axel Dignass (Germany) about his recent publication about the impact of Ustekinumab on health-related quality of life in moderate-to-severe Crohn’s disease which was an open-label, multicenter, randomized study evaluated the quality of life prospectively in Crohn’s patients who treated with Ustekinumab.
May 2017
30. My Crohn's Disease Story
I was diagnosed with Crohn’s disease when I was 7 years old. It was a scary, confusing time in my life, and while I’d love to say I’ve figured it all out since then, the truth is that this disease constantly keeps me on my toes. I’m someone who loves to live life according to pla ... Show More
21m 23s
Jan 2024
Patient-Centered Palliative Care
JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Alexander K. Smith, MD, MS, MPH, University of California, San Francisco, discuss the importance of 2 new palliative care trials that were recently published in JAMA. Related Content: A Tale of 2 Palliative Care Trials Associa ... Show More
14m 58s
Mar 2023
Curing cancer, from bench to bedside
Medical research sits at the intersection of the lab and the clinic. It's critical for translating breakthrough science into possible treatments for people. It's most successful when scientists and clinicians collaborate. Today, we're talking with Professor Anthony Joshua, one of ... Show More
22m 5s
Nov 2021
Genomic adaptation, 2021 AMA Research Challenge finalist
Marielisa Cabrera Sánchez, second-year medical student at Puerto Rico School of Medicine and AMA Research Challenge finalist, shares about her early enthusiasm for understanding microbes and infectious diseases, as well as how COVID-19 has impacted her research in genomic adaptat ... Show More
17m 22s